SBTX Annual EBITDA
-$88.80 M
-$56.52 M-175.09%
31 December 2021
Summary:
As of February 2, 2025, SBTX annual earnings before interest, taxes, depreciation & amortization is -$88.80 million, with the most recent change of -$56.52 million (-175.09%) on December 31, 2021. During the last 3 years, it has fallen by -$70.96 million (-397.76%).SBTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBTX Quarterly EBITDA
-$18.52 M
+$1.06 M+5.40%
30 September 2022
Summary:
As of February 2, 2025, SBTX quarterly earnings before interest, taxes, depreciation & amortization is -$18.52 million, with the most recent change of +$1.06 million (+5.40%) on September 30, 2022. Over the past year, it has increased by +$3.96 million (+17.63%).SBTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBTX TTM EBITDA
-$85.90 M
+$3.96 M+4.41%
30 September 2022
Summary:
As of February 2, 2025, SBTX TTM earnings before interest, taxes, depreciation & amortization is -$85.90 million, with the most recent change of +$3.96 million (+4.41%) on September 30, 2022. Over the past year, it has dropped by -$7.51 million (-9.58%).SBTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBTX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -175.1% | +17.6% | -9.6% |
| 3 y3 years | -397.8% | -172.6% | -1164.6% |
| 5 y5 years | -397.8% | -172.6% | -1164.6% |
SBTX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +397.8% | +262.9% | +1164.6% |
Silverback Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$18.52 M(-5.4%) | -$85.90 M(-4.4%) |
| June 2022 | - | -$19.57 M(-20.1%) | -$89.86 M(-5.0%) |
| Mar 2022 | - | -$24.49 M(+5.0%) | -$94.59 M(+6.5%) |
| Dec 2021 | -$88.80 M | -$23.32 M(+3.7%) | -$88.80 M(+13.3%) |
| Sept 2021 | - | -$22.48 M(-7.5%) | -$78.39 M(+22.8%) |
| June 2021 | - | -$24.30 M(+30.0%) | -$63.85 M(+39.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$18.70 M(+44.8%) | -$45.88 M(+42.1%) |
| Dec 2020 | -$32.28 M(+37.2%) | -$12.91 M(+62.6%) | -$32.28 M(+23.4%) |
| Sept 2020 | - | -$7.94 M(+25.5%) | -$26.16 M(+43.6%) |
| June 2020 | - | -$6.33 M(+23.9%) | -$18.22 M(+53.2%) |
| Mar 2020 | - | -$5.10 M(-24.9%) | -$11.90 M(+75.1%) |
| Dec 2019 | -$23.52 M(+31.9%) | -$6.79 M | -$6.79 M |
| Dec 2018 | -$17.84 M | - | - |
FAQ
- What is Silverback Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Silverback Therapeutics?
- What is Silverback Therapeutics annual EBITDA year-on-year change?
- What is Silverback Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Silverback Therapeutics?
- What is Silverback Therapeutics quarterly EBITDA year-on-year change?
- What is Silverback Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Silverback Therapeutics?
- What is Silverback Therapeutics TTM EBITDA year-on-year change?
What is Silverback Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of SBTX is -$88.80 M
What is the all time high annual EBITDA for Silverback Therapeutics?
Silverback Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$17.84 M
What is Silverback Therapeutics annual EBITDA year-on-year change?
Over the past year, SBTX annual earnings before interest, taxes, depreciation & amortization has changed by -$56.52 M (-175.09%)
What is Silverback Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of SBTX is -$18.52 M
What is the all time high quarterly EBITDA for Silverback Therapeutics?
Silverback Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$5.10 M
What is Silverback Therapeutics quarterly EBITDA year-on-year change?
Over the past year, SBTX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$3.96 M (+17.63%)
What is Silverback Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of SBTX is -$85.90 M
What is the all time high TTM EBITDA for Silverback Therapeutics?
Silverback Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$6.79 M
What is Silverback Therapeutics TTM EBITDA year-on-year change?
Over the past year, SBTX TTM earnings before interest, taxes, depreciation & amortization has changed by -$7.51 M (-9.58%)